Article Published in Health Matrix: The Journal of Law-Medicine: Public Citizen’s Advocacy Campaign Opposing FDA Approval of Aducanumab for Alzheimer’s Disease: The Fight Against Regulatory Capture

View as PDF

In an edited version of the annual Oliver C. Schroeder, Jr. Scholar-in-Residence Lecture sponsored by the Law-Medicine Center on October 4, 2021, at Case Western Reserve University School of Law, Dr. Michael Carome described Public Citizen’s advocacy campaign opposing Food and Drug Administration (FDA) approval of aducanumab for treating Alzheimer’s disease and seeking to hold the agency accountable for its inappropriately close collaboration with Biogen and for its reckless decision to approve the drug.

See Public Citizen’s other work on aducanumab.